Yannick Allanore Selected Research

Yannick Allanore Research Topics

Disease

109	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 01/2003
47	Fibrosis (Cirrhosis) 03/2024 - 07/2006
30	Rheumatoid Arthritis 12/2023 - 03/2006
30	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 06/2008
20	Diffuse Scleroderma (Progressive Systemic Sclerosis) 03/2024 - 06/2004
16	Inflammation (Inflammations) 12/2023 - 03/2006
14	digital ulcers 12/2023 - 03/2010
14	Pulmonary Hypertension 10/2022 - 07/2006
13	Arthritis (Polyarthritis) 08/2023 - 07/2003
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2023 - 01/2010
9	Rheumatic Diseases (Rheumatism) 11/2023 - 12/2013
9	Infections 08/2023 - 07/2012
9	Connective Tissue Diseases (Connective Tissue Disease) 08/2023 - 05/2008
9	Pulmonary Arterial Hypertension 01/2020 - 05/2008
6	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 03/2011
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 11/2011
6	Neoplasms (Cancer) 11/2021 - 07/2006
6	Disease Progression 11/2020 - 01/2016
5	Synovitis 01/2023 - 01/2010
5	Pain (Aches) 11/2022 - 05/2005
5	Vascular Remodeling 01/2022 - 01/2011
4	Ulcer 12/2023 - 02/2008
3	Hypertension (High Blood Pressure) 09/2023 - 01/2016
3	COVID-19 08/2023 - 01/2022
3	Hypoxia (Hypoxemia) 01/2016 - 08/2011
3	Telangiectasis (Telangiectasia) 06/2014 - 11/2013
2	Psoriatic Arthritis 11/2023 - 12/2014
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2023 - 06/2019
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 12/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
2	Lung Diseases (Lung Disease) 01/2022 - 03/2020
2	Cicatrix (Scar) 01/2022 - 01/2015
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 02/2012
2	Pneumonia (Pneumonitis) 01/2021 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 07/2009
2	Wounds and Injuries (Trauma) 05/2020 - 12/2016
2	Raynaud Disease (Raynaud's Disease) 01/2020 - 06/2014
2	Ankylosing Spondylitis 01/2020 - 05/2012
2	Idiopathic Pulmonary Fibrosis 01/2020 - 12/2018
2	Heart Failure 11/2019 - 01/2014
2	Chronic Disease (Chronic Diseases) 02/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2008
17	AntibodiesIBA 12/2023 - 08/2006
17	AutoantibodiesIBA 11/2022 - 01/2005
15	Rituximab (Mabthera)FDA Link 12/2023 - 01/2008
13	CollagenIBA 08/2023 - 01/2003
12	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 03/2011
12	nintedanibIBA 06/2023 - 01/2021
10	C-Reactive ProteinIBA 12/2023 - 08/2008
9	tocilizumab (atlizumab)FDA Link 06/2023 - 07/2013
8	Infliximab (Remicade)FDA Link 01/2021 - 06/2003
8	Abatacept (Orencia)FDA Link 12/2020 - 07/2013
7	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 07/2003
6	anti-scl-70 autoantibodiesIBA 06/2023 - 07/2015
5	riociguatIBA 03/2024 - 01/2017
5	Biosimilar PharmaceuticalsIBA 11/2023 - 01/2018
5	Etanercept (Enbrel)FDA Link 11/2023 - 07/2003
4	EnzymesIBA 03/2024 - 09/2011
4	Carbon MonoxideIBA 12/2023 - 01/2014
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 05/2005
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 06/2008
4	Antinuclear AntibodiesIBA 12/2021 - 01/2005
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 05/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015 - 07/2003
3	Rheumatoid FactorIBA 12/2023 - 08/2008
3	Anti-Citrullinated Protein AntibodiesIBA 01/2023 - 12/2014
3	InterferonsIBA 11/2022 - 05/2010
3	Interleukin-13IBA 12/2020 - 08/2006
3	ametantrone (HAQ)IBA 10/2020 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 06/2013
3	Antirheumatic Agents (DMARD)IBA 03/2020 - 01/2018
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2013
3	CytokinesIBA 01/2019 - 03/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2017 - 05/2015
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 02/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2004
3	Hydroxyproline (4 Hydroxyproline)IBA 05/2015 - 03/2011
3	erucylphosphocholineIBA 04/2013 - 11/2011
3	Fibrillin-1IBA 04/2010 - 12/2007
3	Proteins (Proteins, Gene)FDA Link 09/2008 - 05/2004
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2005 - 05/2004
2	Messenger RNA (mRNA)IBA 03/2024 - 01/2022
2	anticentromere antibodyIBA 10/2023 - 01/2011
2	Immunosuppressive Agents (Immunosuppressants)IBA 08/2023 - 12/2013
2	Chimeric Antigen ReceptorsIBA 08/2023 - 11/2021
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2023 - 06/2016
2	Monoclonal AntibodiesIBA 06/2023 - 06/2013
2	Tyrosine Kinase InhibitorsIBA 06/2023 - 10/2022
2	Semaphorins (Semaphorin)IBA 01/2023 - 01/2021
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2021 - 07/2006
2	Immunomodulating AgentsIBA 01/2021 - 07/2006
2	CT-P13IBA 01/2021 - 01/2021
2	InterleukinsIBA 12/2020 - 01/2019
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2020 - 01/2019
2	Iloprost (Ventavis)FDA Link 02/2019 - 12/2012

Therapy/Procedure

28	Therapeutics 12/2023 - 07/2003
3	Immunotherapy 06/2017 - 03/2014
2	Liver Transplantation 10/2023 - 03/2010
2	Injections 01/2022 - 05/2015